Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
1.450
+0.050 (3.57%)
At close: Aug 1, 2025, 4:00 PM
1.450
0.00 (0.00%)
After-hours: Aug 1, 2025, 4:00 PM EDT
Climb Bio Market Cap
Climb Bio has a market cap or net worth of $97.31 million as of August 1, 2025. Its market cap has decreased by -79.36% in one year.
Market Cap
97.31M
Enterprise Value
-102.76M
1-Year Change
-79.36%
Ranking
Category
Stock Price
1.45
Market Cap Chart
Since August 10, 2021, Climb Bio's market cap has decreased from $403.20M to $97.31M, a decrease of -75.87%. That is a compound annual growth rate of -30.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 94.61M | -21.81% |
| Dec 31, 2024 | 121.00M | 62.54% |
| Dec 29, 2023 | 74.45M | -23.65% |
| Dec 30, 2022 | 97.50M | -64.90% |
| Dec 31, 2021 | 277.76M | -31.11% |
| Aug 10, 2021 | 403.20M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 663.70B |
| Johnson & Johnson | 396.61B |
| AbbVie | 332.79B |
| AstraZeneca | 236.88B |
| UnitedHealth Group | 225.33B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 219.71B |
| Novo Nordisk | 213.92B |